Interleukin-6R?/CD126 Chimeric Monoclonal Antibody

CAT N°: 37171
Price:

851.00 723.35

Interleukin-6R? (IL-6R?), also known as CD126, is a type I cytokine receptor.{16580} It is composed of an immunoglobulin-like domain, a cytokine-binding domain, a transmembrane domain, and a cytoplasmic domain and forms a heteromeric complex with IL-6 and gp130, which is the signal transducing subunit of the IL-6R that primarily acts through the JAK/STAT3 pathway.{65404} IL-6R? is expressed in hepatocytes and monocytes and is localized to the plasma membrane but also exists as a soluble form (sIL-6R?) that is primarily generated via proteolytic cleavage of membrane-bound IL-6R?, but can also be formed via alternative splicing.{65405,65406,65407} Binding of IL-6 to membrane-bound IL-6R?, known as classical signaling, upregulates the synthesis of acute phase proteins, induces lipolysis in the liver, and induces the differentiation of T and B cells and is primarily anti-inflammatory.{46747,46748} Trans-signaling consists of IL-6 binding to sIL-6R, which has various pro-inflammatory effects. Knockdown of IL6R increases sensitivity to tamoxifen in breast cancer cells.{65408} Formulations containing chimeric anti-IL-6R? monoclonal antibodies have been used in the treatment of rheumatoid arthritis, idiopathic arthritis, giant cell arteritis, cytokine release syndrome, and COVID-19. Cayman’s Interleukin-6R?/CD126 Chimeric Monoclonal Antibody was produced recombinantly from the original rhPM-1 antibody and can be used for ELISA. The rhPM-1 antibody was generated by CDR grafting of mouse PM-1 antibody onto human REI and NEW framework regions.{69140}

We also advise you

TAF 10 Peptide

TAF 10 Peptide

TAF10 is one of many protein factors or coactivators associated with RNA polymerase II activity.{16903} One vial of this peptide...

€191.00
View